Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page no longer displays a 403 Forbidden error. It now shows the study details content for the record, restoring access to the core information.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, replacing the main content with an access-restricted notice. The header and footer remain, but the study information is no longer accessible.SummaryDifference17%

- Check52 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the study record on ClinicalTrials.gov. This update may include small content edits or formatting adjustments but does not alter the study data or eligibility criteria.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the study page.SummaryDifference0.0%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.